SB 9200
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for SB 9200, covering 2020-02-11 to 2020-02-11. Get the full timeline:
Most recent: Clinical Trial Update: A Study Evaluating the Safety, Pharmacokinetics, and Antiviral Efficacy of SB 9200 in Subjects Infected With Chronic HBV [Phase 2]